Arbutus Biopharma Corp
General ticker "ABUS" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $660.8M
Arbutus Biopharma Corp follows the US Stock Market performance with the rate: 50.0%.
Estimated limits based on current volatility of 2.8%: low 3.09$, high 3.27$
Factors to consider:
- Earnings for 9 months up through Q3 are close to our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [1.61$, 3.62$]
- 2024-12-30 to 2025-12-30 estimated range: [2.00$, 4.25$]
Financial Metrics affecting the ABUS estimates:
- Negative: Non-GAAP EPS, $ of -0.44 <= 0.10
- Negative: Operating profit margin, % of -81.15 <= 1.03
- Negative: Operating cash flow per share per price, % of -19.72 <= 2.35
- Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85
- Negative: negative Net income
- Negative: 0 < Interest expense per share, $ of 0
Short-term ABUS quotes
Long-term ABUS plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $10.99MM | $39.02MM | $18.14MM |
| Operating Expenses | $84.51MM | $104.47MM | $96.24MM |
| Operating Income | $-73.52MM | $-65.46MM | $-78.10MM |
| Non-Operating Income | $-2.73MM | $0.44MM | $5.25MM |
| Interest Expense | $2.86MM | $1.73MM | $0.46MM |
| R&D Expense | $65.50MM | $84.41MM | $73.70MM |
| Income(Loss) | $-76.25MM | $-65.01MM | $-72.85MM |
| Taxes | $0.00MM | $4.44MM | $0.00MM |
| Profit(Loss) | $-76.25MM | $-69.46MM | $-72.85MM |
| Stockholders Equity | $169.44MM | $136.85MM | $106.02MM |
| Inventory | $4.45MM | $2.87MM | $0.00MM |
| Assets | $204.49MM | $195.42MM | $144.40MM |
| Operating Cash Flow | $-67.53MM | $-35.36MM | $-85.94MM |
| Capital expenditure | $0.81MM | $0.51MM | $1.01MM |
| Investing Cash Flow | $-12.68MM | $-74.94MM | $50.77MM |
| Financing Cash Flow | $137.24MM | $31.81MM | $30.65MM |
| Earnings Per Share* | $-0.73 | $-0.46 | $-0.44 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.